BIOMAT Database Logo BIOMAT Database Logo

Tetanus despite preexisting antitetanus antibody. 1978

S A Berger, and C E Cherubin, and S Nelson, and L Levine

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D006556 Heroin Dependence Strong dependence or addiction, both physiological and emotional, upon HEROIN. Heroin Abuse,Heroin Addiction,Heroin Smoking,Abuse, Heroin,Addiction, Heroin,Dependence, Heroin,Heroin Smokings,Smoking, Heroin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D013742 Tetanus A disease caused by tetanospasmin, a powerful protein toxin produced by CLOSTRIDIUM TETANI. Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia. Localized tetanus presents itself as a mild condition with manifestations restricted to muscles near the wound. It may progress to the generalized form. Clostridium tetani Infection,Clostridium tetani Infections,Infection, Clostridium tetani,Infections, Clostridium tetani
D013743 Tetanus Antitoxin An antitoxin used for the treatment of TETANUS. Antitoxin, Tetanus

Related Publications

S A Berger, and C E Cherubin, and S Nelson, and L Levine
Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response.
November 1999, Infection and immunity,
S A Berger, and C E Cherubin, and S Nelson, and L Levine
Neonatal tetanus despite immunization and protective antitoxin antibody.
April 1995, The Journal of infectious diseases,
S A Berger, and C E Cherubin, and S Nelson, and L Levine
Tetanus prophylaxis--antibiotics versus antitetanus serum.
April 1970, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
S A Berger, and C E Cherubin, and S Nelson, and L Levine
A case of clinical tetanus in a patient with protective antitetanus antibody level.
January 2007, Southern medical journal,
S A Berger, and C E Cherubin, and S Nelson, and L Levine
Clinical tetanus despite a protective level of toxin-neutralizing antibody.
March 1986, JAMA,
S A Berger, and C E Cherubin, and S Nelson, and L Levine
Human Antitetanus Serum in the Treatment of Tetanus.
April 1963, British medical journal,
S A Berger, and C E Cherubin, and S Nelson, and L Levine
Intrathecal antitetanus serum in the management of tetanus.
January 1982, East African medical journal,
S A Berger, and C E Cherubin, and S Nelson, and L Levine
[Treatment of tetanus by small doses of antitetanus serum].
August 1969, Vrachebnoe delo,
S A Berger, and C E Cherubin, and S Nelson, and L Levine
[Antitetanus antioxin immunity in connection with typhoid-tetanus vaccination].
July 1956, Nepegeszsegugy,
S A Berger, and C E Cherubin, and S Nelson, and L Levine
[The treatment of tetanus by intrathecal heterologous antitetanus serum].
January 1978, Bulletin de la Societe medicale d'Afrique noire de langue francaise,
Copied contents to your clipboard!